Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin infusion in living donor liver transplantation
PACTR201402000752252Completed
- Sponsor
- National Liver Institute
- Start
- Aug 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Trial of terlipressin in hepatic disease (2 arms), sponsored by National Liver Institute. Primary endpoint: renal function. Started Aug 2013; status: completed.
02
Drugs
terlipressin
03
Conditions
hepatic disease
Beyond the preview
Go deeper on PACTR201402000752252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201402000752252.